The existing licensing agreements between AI companies and rights holders exemplify how the two communities can work together and ensure that strong IP and strong AI co-exist.
CCC recently moderated a panel discussion on best practices and strategies for Medical Affairs teams when acquiring, managing, and disseminating scientific articles and other content to internal stakeholders.
The EU has just released the much-anticipated Code of Practice for General-Purpose AI, which includes 3 chapters, including one dedicated to Copyright.
CCC’s Lauren Tulloch delves into the evolving intersection of AI in the workplace and copyright law on a recent episode of the AI for Pharma Podcast.
CCC’s Roy Kaufman argues that the path to ethical and practical AI begins not with radical reinvention, but with a firm commitment to existing copyright principles, specifically, licensing.
